Cargando…
microRNA-27a-3p Down-regulation Inhibits Malignant Biological Behaviors of Ovarian Cancer by Targeting BTG1
Ovarian cancer is the most deadly malignant tumor. MicroRNA-27a-3p (miR-27a-3p) was a tumor oncogene in various cancers. However, the role and mechanism of miR-27a-3p in ovarian cancer are still unknown. In this study, we found that miR-27a-3p over-expression could significantly promote the viabilit...
Autores principales: | Li, Enfang, Han, Ke, Zhou, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689206/ https://www.ncbi.nlm.nih.gov/pubmed/31410369 http://dx.doi.org/10.1515/med-2019-0065 |
Ejemplares similares
-
microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma
por: Enkhnaran, Bilegsaikhan, et al.
Publicado: (2022) -
MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells
por: Zhu, Bei, et al.
Publicado: (2020) -
BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020) -
Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022) -
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2
por: Zhou, Lin, et al.
Publicado: (2016)